Magnetic Resonance Contrast Activity

Name
Magnetic Resonance Contrast Activity
Accession Number
DBCAT004125
Description

Not Available

Drugs
DrugDrug Description
GadodiamideA gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity.
Gadopentetic acidA gadolinium compound used as a contrast agent in MRIs.
GadoversetamideA gadolinium compound used as a contrast agent in MRI tests of the brain, spine, and liver.
Gadoxetic acidA gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize the liver.
FerumoxytolAn intravenous iron replacement product used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), or in patients who are unable to tolerate or who have not responded adequately to oral iron supplementation.
Gadofosveset trisodiumAn intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease.
GadoteridolA gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity.
Gadobenic acidA gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity.
MangafodipirAn organ-specific paramagnetic contrast agent indicated for the imaging of the hepatobiliary system and detecting lesions in the liver and pancreas.
Manganese cationA transition metal used for supplementation of manganese during Total Parenteral Nutrition (TPN).
GadobutrolA gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity.
Gadolinium cation (3+)Not Annotated
GadopiclenolA gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity.
Drugs & Drug Targets
DrugTargetType
Gadopentetic acid6-phosphogluconate dehydrogenase, decarboxylatingtarget
Gadoxetic acidSolute carrier organic anion transporter family member 1B1transporter
Gadoxetic acidSolute carrier organic anion transporter family member 1B3transporter
Gadoxetic acidATP-binding cassette sub-family C member 3transporter
Gadoxetic acidATP-binding cassette sub-family C member 4transporter
Gadoxetic acidATP-binding cassette sub-family C member 2transporter
FerumoxytolSerotransferrincarrier
Gadofosveset trisodiumAlbumincarrier
Gadobenic acidAlbumincarrier
Gadobenic acidATP-binding cassette sub-family C member 2transporter
Gadobenic acidAlbumintarget
MangafodipirAlpha-2-macroglobulincarrier
MangafodipirAlbumincarrier
MangafodipirSuperoxide dismutase [Mn], mitochondrialenzyme
MangafodipirNatural resistance-associated macrophage protein 2transporter
Manganese cationCytoplasmic aconitate hydrataseenzyme
Manganese cationIsocitrate dehydrogenase [NAD] subunit alpha, mitochondrialtarget
Manganese cationIsocitrate dehydrogenase [NAD] subunit gamma, mitochondrialtarget
Manganese cationTGF-beta-activated kinase 1 and MAP3K7-binding protein 1target
Manganese cationArginase-1target
Manganese cationSerotransferrincarrier
Manganese cationAlbumincarrier
Manganese cationMetal cation symporter ZIP14transporter
Manganese cationSuperoxide dismutase [Mn], mitochondrialtarget
Manganese cationGlutamine synthetasetarget
Manganese cationPhosphoenolpyruvate Carboxykinasestarget
Manganese cationNatural resistance-associated macrophage protein 2transporter
Manganese cationCalcium/manganese antiporter SLC30A10transporter
Manganese cationCeruloplasmincarrier
Manganese cationTransient receptor potential cation channel subfamily M member 7transporter
Manganese cationSerine/threonine-protein phosphatase PP1-gamma catalytic subunittarget